As of 9:30 AM on the 5th, Ilyang Pharmaceutical is trading at 52,300 KRW, up 3.36% from the previous day. This represents a 60.43% increase compared to May 22. Ilyang Pharmaceutical is known as a pharmaceutical company specializing in drinks such as Wonbidi.
Over the past 5 days, individual investors have net purchased 68,364 shares, while foreigners and institutions have net sold 44,086 shares and 11,095 shares respectively.
On May 29, Ilyang Pharmaceutical became a market issue with the news of approval for COVID-19 treatment clinical trials, causing consecutive sharp rises.
※ This article was generated in real-time by an automated article creation algorithm jointly developed by Asia Economy and financial AI specialist Thinkpool.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
